Skip to main content
Premium Trial:

Request an Annual Quote

Partek Licenses Software to British Pharma Renovo

NEW YORK, Jan. 13 (GenomeWeb News) - Partek has licensed its Parteksoftware to Renovo, a British drug maker, the company said yesterday.

 

Renovo, based in Manchester, bought a site license to the software to help it develop drugs to prevent scarring. Partek is located in St. Louis.

 

Partek software enables researchers to identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.